UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Targeting protein-tyrosine phosphatases in breast cancer

Oncotarget, 2012-05, Vol.3 (5), p.514-515

2012

Link zum Volltext

Verfügbarkeit prüfen

Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages

Oncotarget, 2016-12, Vol.7 (50), p.82289-82304

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

Oncotarget, 2015-03, Vol.6 (8), p.6191-6202

2015

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue

Oncotarget, 2017-04, Vol.8 (14), p.22353-22360

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Oncotarget, 2016-05, Vol.7 (19), p.28697-28710

2016

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid metabolism in breast cancer subtypes

Oncotarget, 2017-04, Vol.8 (17), p.29487-29500

Monaco, Marie E

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Oncotarget, 2016-04, Vol.7 (16), p.21922-21938

2016

Link zum Volltext

Verfügbarkeit prüfen

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Oncotarget, 2015-09, Vol.6 (28), p.26483-26493

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

Oncotarget, 2016-08, Vol.7 (31), p.49349-49367

2016

Link zum Volltext

Verfügbarkeit prüfen

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling

Oncotarget, 2017-01, Vol.8 (4), p.5976-5991

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Oncotarget, 2016-02, Vol.7 (8), p.9250-9270

2016

Link zum Volltext

Verfügbarkeit prüfen

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Oncotarget, 2016-01, Vol.7 (4), p.4428-4441

2016

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

Oncotarget, 2015-06, Vol.6 (17), p.14913-14925

2015

Link zum Volltext

Verfügbarkeit prüfen

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

Oncotarget, 2015-05, Vol.6 (13), p.11585-11599

2015

Link zum Volltext

Verfügbarkeit prüfen

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

Oncotarget, 2016-11, Vol.7 (45), p.73817-73829

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

Oncotarget, 2017-06, Vol.8 (24), p.39230-39240

2017

Link zum Volltext

Verfügbarkeit prüfen

CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway

Oncotarget, 2016-03, Vol.7 (13), p.15632-15647

2016

Link zum Volltext

Verfügbarkeit prüfen

IκBζ: an emerging player in cancer

Oncotarget, 2016-10, Vol.7 (40), p.66310-66322

2016

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

Oncotarget, 2016-03, Vol.7 (12), p.14727-14741

2016

Link zum Volltext

Verfügbarkeit prüfen

Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells

Oncotarget, 2016-11, Vol.7 (44), p.71580-71593

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells

Oncotarget, 2016-05, Vol.7 (18), p.26709-26723

2016

Link zum Volltext

Verfügbarkeit prüfen

Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway

Oncotarget, 2017-04, Vol.8 (15), p.25097-25106

2017

Link zum Volltext

Verfügbarkeit prüfen

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development

Oncotarget, 2015-04, Vol.6 (11), p.9355-9369

2015

Link zum Volltext

Verfügbarkeit prüfen

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Oncotarget, 2014-05, Vol.5 (10), p.3145-3158

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieOncotarget

ThemaHumans

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(43)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Cell Biology
(43)
Oncology
(43)
Science & Technology
(43)
Research Paper
(35)
Female
(29)
Animals
(24)
Cell Line, Tumor
(19)
Mice
(19)
Breast Neoplasms - Pathology
(14)
Breast Cancer
(13)
Signal Transduction
(12)
Gene Expression Regulation, Neoplastic
(10)
Male
(9)
Mice, Nude
(9)
Rna Interference
(9)
Breast Neoplasms - Drug Therapy
(8)
Breast Neoplasms - Metabolism
(8)
Signal Transduction - Drug Effects
(8)

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(43)
EZB Electronic Journals Library
(43)

Menü

Weitere Dienste

Einstellungen

Targeting protein-tyrosine phosphatases in breast cancer

Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Fatty acid metabolism in breast cancer subtypes

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway

IκBζ: an emerging player in cancer

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells

Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells

Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway

A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Aktive Filter

Suchergebnisse filtern